UPDATE: Eli Lilly Posts 31% Rise In Q2 Profit, Lifts Full-Year Outlook


27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.


Eli Lilly & Co (NYSE: LLY) reported a 31% rise in its second-quarter earnings. Eli Lilly lifted its full-year adjusted earnings forecast to $4.28 to $4.38 per share, versus its earlier view of $3.82 to $3.97 per share.Eli Lilly's quarterly profit surged to $1.21 billion, or $1.11 per share, from $923.6 million, or $0.83 per share, in the year-ago period. Excluding one-time items, its earnings climbed to $1.16 per share from $0.83 per share. Its revenue increased 5.9% to $5.93 billion. However, analysts were expecting earnings of $1 per share on revenue of $5.82 billion. Eli Lilly's gross margin widened to 80.3% from 79.5%. Eli Lilly shares closed at $50.99 yesterday.

27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.


ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Posted In: EarningsNewsGuidanceprofit